Decheng Capital

About

Decheng Capital is a global life-sciences and healthcare investment firm backing early-stage scientific innovation and growth-stage healthcare companies across biopharma, diagnostics, tools, medical devices and services. It reports more than $2.5 billion in assets under management.

Sectors

• Life Sciences
• Healthtech / Digital Health

Notable investments

• GRAIL
• Adaptive Biotechnologies
• Invitae
• Zentalis
• Mammoth Biosciences
• CG Oncology
• ACELYRIN
• Cue Health
• Arcus Biosciences
• Everest Medicines

Investors

• Min CuiFounder & Managing Director→
• Victor Tong Jr.Managing Director→
• Peter ColabuonoManaging Director→
• Dayton MisfeldtPartner→
• Tony TongPartner→
• Qiang XuPartner→
• Wei XuPartner→
• Aaron LiPrincipal→
• Shengyang JinVice President→
• Michael NotarasVice President→
• Joan ChenVice President→
• Claire ZhangSenior Associate→